Shuliang Zhang

Title: Shuliang Zhang: Innovator in Hematology Engineering

Introduction

Shuliang Zhang is a prominent inventor based in Miami, FL, known for his significant contributions to hematology engineering. With four patents to his name, Zhang has developed innovative methods and systems that enhance the analysis of blood parameters, thereby improving diagnostic capabilities in clinical settings.

Latest Patents

Zhang's latest patents showcase his expertise in developing automated systems for analyzing platelet parameters. One notable patent is titled "Systems and methods for platelet count with clump adjustment." This invention encompasses automated techniques for analyzing platelet conditions based on biological samples obtained from an individual's blood. The patented method correlates direct current (DC) impedance and light measurement data with platelet evaluations, providing a more accurate assessment of a patient's health.

Another important patent is his "Method of correction of particle interference to hemoglobin measurement." This innovation addresses the challenges of measuring hemoglobin concentrations in blood samples by correcting for the interference caused by cellular particles. The method involves lysing red blood cells, measuring absorbance at specific wavelengths, and using the concentration and size of remaining cellular particles to obtain a corrected hemoglobin concentration. This advancement is crucial for improving the accuracy of hematology analyzers.

Career Highlights

Throughout his career, Shuliang Zhang has served in key roles at notable companies in the medical technology field, such as Beckman Coulter, Inc. and Coulter International Corporation. His work with these organizations has been instrumental in the development of advanced hematology products that benefit both practitioners and patients.

Collaborations

Zhang has collaborated with talented professionals, including Min Zheng and Ziling Huo, enhancing the innovative process through teamwork and shared expertise. These collaborations have not only contributed to the successful development of his patents but have also facilitated the sharing of knowledge within the field of hematology.

Conclusion

Shuliang Zhang's dedication to innovation in hematology is evident through his patented inventions and professional career. His work continues to impact medical diagnostics positively, demonstrating the vital role of inventors in advancing healthcare technology. As he continues to explore new avenues for innovation, the medical community eagerly anticipates his future contributions.